ACQUISITIONS and MERGERS

The combination of companies expands access to sudden cardiac arrest (SCA) preparedness solutions to customers nationwide.

“The close of this acquisition allows us to integrate the Lumenis laser portfolio – including the differentiated MOSES™ technology – with our category leading kidney stone management and benign prostatic hyperplasia offerings while expanding our global footprint to accelerate growth throughout Europe and Asia,” said Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, Boston Scientific.

CartiHeal, is the developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device Designation by the FDA last year.

Spectrum Health relationship to fuel additional growth in sales to hospital systems. Follow-on acquisitions a focus to expand manufacturer’s product portfolio

The acquisition is expected to close toward the end of Medtronic’s current fiscal year, subject to the satisfaction of customary closing conditions, including receipt of regulatory clearances and approval by Intersect ENT’s stockholders.